AP707 Clinical Aesthetic Procedures: Botulinum Toxin Injections for the Face (Y/651/9196) Assignment Brief 2026

Qualifi Level 7 Certificate in Clinical Aesthetic Procedures: Botulinum Toxin Injections (610/7010/5)

• legal, regulatory and organisational requirements
• client procedure plan and areas to be treated
• advice, support and guidance
• emergency plan
• medicine management policy
• pain management strategy

1.2 Describe the types, composition and pharmacological effects of chemical compounds in botulinum toxin solutions to include:

• how religion and belief can prohibit a botulinum toxin type A procedure

1.3 Explain the physiological effect botulinum toxin type A solution has on the targeted and surrounding facial muscle structures to include:

• adaptation of injection techniques
• adaptation of depth and placement

1.5 Explain the purpose, use and limitations of botulinum toxin type A procedures in relation to:

• past and current medical history
• previous non-surgical cosmetic and/or dental procedure history
• relevant lifestyle factors
• contraindicated medication and medical conditions
• the client’s physical and psychological suitability for the non-surgical cosmetic procedure
• client expectations

1.6 Explain the regulatory and legislative requirements for prescription-only medicines to include licensed and offlabel product use

1.7 Explain the licensed indicated use of prescription-only medicines and when and why they can be used off-label considering:

• safety
• treatment area
• suitability
• agreement with the regulated independent prescriber

1.8 Explain the legislative requirements and restrictions for sourcing, storing and using licensed topical anaesthetics

1.9 Describe the health and safety responsibilities in line with legislation before, during and after the botulinum toxin type A procedure

1.10 Explain the legislative and indemnity requirements for gaining signed, informed consent for the elective nonsurgical cosmetic procedure

1.11 Explain the legislative, insurance and organisational requirements for taking and storing visual media of the client’s treatment area

1.12 Explain the legislative and regulatory requirements for completing and storing the client’s medical and nonsurgical cosmetic procedure records

2.2 Discuss client objectives, concerns, expectations and desired outcomes to inform the botulinum toxin type A procedure plan including; fee structure, treatment options, and alternative treatment options

2.3 Establish the botulinum toxin type A procedure plan in accordance with legislative requirements and organisational policies and procedures

2.4 Reiterate, confirm and agree with the client that they have understood the proposed botulinum toxin type A procedure and pain management to including:

• contra-actions
• adverse reactions

2.5 Obtain and review the client’s written informed consent for the botulinum toxin type A procedure and pain management, allowing an adequate time scale for the client to make an informed choice

2.6 Obtain the fulfilled prescription from the pharmacist with the client’s informed consent to include:

• patient-specific direction
• saline reconstitution solutions
• device and needle type
• storage instructions
• waste disposal protocol

3.2 Prepare the client’s treatment area in line with botulinum toxin type A protocol and risk management strategies, including marking the procedure sites where applicable

3.3 Inject the botulinum toxin type A solution with a sterile, single-use needle following the botulinum toxin type A procedure protocol to include:

• adaptation of injection techniques, depth and placement
• in accordance with the preprocedure markings if applicable

3.4 Monitor the client’s health, wellbeing and skin response throughout the botulinum toxin type A procedure, ensuring compliance with legislative requirements and organisational policies and procedures

3.5 In the event of an adverse reaction or incident, the aesthetic practitioner must take prompt corrective action following the emergency plan to include:

• promptly obtain medical intervention from the designated healthcare professional when complications arise and prescription-only medicine is required

3.6 Conclude the procedure in line with the botulinum toxin type A protocol, legislative requirements and organisational procedures to include:

• removing any pre-procedure markings if applicable

3.7 Capture and securely store clientapproved images of the procedure area in compliance with insurance and organisation requirements

3.8 Complete the client’s non-surgical cosmetic procedure records and store in line with data legislation

• the regulated independent prescriber’s contact details
• emergency plan
• contingency plan in the event of absence

4.2 Discuss the outcomes and agree future procedures with the client

4.3 Discuss, evaluate and record the outcomes with the regulated independent prescriber and agree further action and future procedures

5.2 Explain the importance in engaging in, and documenting continuous professional development including keeping updated on policies, procedures and best practice guidance